In addition, PARP-1 regulates oncogenes, tumor suppressors, and inflammatory genes, providing therapeutic options for cancers driven by specific transcriptional factors, such as prostate cancer with ETS gene fusions (NCT01576172) 66. This evidence concerns the gene PARP1 and prostate cancer.